C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043806 Method of diagnosing an RTK-hyperfunction induced disorder
10/25/2011	US8043620 Wise binding agents and epitopes
10/25/2011	US8043618 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
10/25/2011	US8043617 Human antibodies to human IL-6 receptor
10/25/2011	US8043615 Methods of antagonizing LDCAM and CRTAM
10/25/2011	US8043612 Infection and treatment of neoplasms with vesicular stomatitis virus
10/25/2011	CA2437866C Novel clock gene bmal2
10/25/2011	CA2399865C Novel scavenger receptor
10/25/2011	CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof
10/25/2011	CA2374505C Methods for display of heterodimeric proteins on filamentous phage using pvii and pix, compositions, vectors and combinatorial libraries
10/22/2011	CA2700466A1 Modification of intrinsically disordered sequences for the preparation of vaccines
10/20/2011	WO2011130650A2 Antibodies for the treatment of clostridium difficile-associated infection and disease
10/20/2011	WO2011130644A2 Phosphorylated nf45 biomarkers, antibodies and methods of using same
10/20/2011	WO2011130603A2 Anti-vla-4 antibodies
10/20/2011	WO2011130580A1 Monoclonal antibodies against her2 antigens, and uses therefor
10/20/2011	WO2011130499A1 Anti-polyubiquitin antibodies and methods of use
10/20/2011	WO2011130434A2 Antibodies that bind human cd27 and uses thereof
10/20/2011	WO2011130417A2 HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
10/20/2011	WO2011130377A2 Amyloid-beta binding proteins
10/20/2011	WO2011130340A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011	WO2011130332A1 Glycan arrays for high throughput screening of viruses
10/20/2011	WO2011130328A1 Trail r2-specific multimeric scaffolds
10/20/2011	WO2011130249A2 Methods and compositions for inhibition of treg cells
10/20/2011	WO2011129483A1 Xage-1d marker for diagnosing lung cancer, and diagnostic kit using same
10/20/2011	WO2011129379A1 Novel anti-hsp90 monoclonal antibody
10/20/2011	WO2011128429A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011	WO2011128377A1 Method for the selection of a long-term producing cell
10/20/2011	WO2011128368A1 Immunoglobulin aggregate removal
10/20/2011	WO2011127989A1 Nicotine conjugate vaccine
10/20/2011	WO2011127936A1 Novel treatment for autoimmune diseases
10/20/2011	WO2011127580A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	WO2011127543A1 Proteins that bind pi16 and uses thereof
10/20/2011	WO2011084882A3 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
10/20/2011	WO2011083088A3 Methods for treating colorectal cancer
10/20/2011	WO2011075636A3 Wise binding agents and epitopes
10/20/2011	US20110258740 Genes, proteins and vectors for increasing tolerance of plants and microbes to abiotic stresses and the use thereof
10/20/2011	US20110258710 Methods of Modifying Eukaryotic Cells
10/20/2011	US20110257374 Novel Reagents for Directed Biomarker Signal Amplification
10/20/2011	US20110257373 Ligands that have binding specificity for dc-sign
10/20/2011	US20110257372 Immunoglobulins devoid of light chains
10/20/2011	US20110257371 Methods of Treating Chronic Pain
10/20/2011	US20110257080 Hepatitis B Virus Compositions and Methods of Use
10/20/2011	US20110257044 Structure-based construction of human antibody library
10/20/2011	US20110257036 Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof
10/20/2011	US20110257028 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds
10/20/2011	US20110256636 Methods and reagents for diagnosing rheumatoid arthrtis
10/20/2011	US20110256635 Soluble human st-2 antibodies and assays
10/20/2011	US20110256569 Complex of a chaperone with beta-amyloid and methods employing this complex
10/20/2011	US20110256554 Methods for predicting pregnancy outcome in a subject by hcg assay
10/20/2011	US20110256553 Methods
10/20/2011	US20110256549 Novel reagents for directed biomarker signal amplification
10/20/2011	US20110256543 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
10/20/2011	US20110256534 Prediction of antiviral therapy response
10/20/2011	US20110256525 Compositions and methods for purifying and crystallizing molecules of interest
10/20/2011	US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011	US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011	US20110256154 Anti-erbb3 antibodies
10/20/2011	US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256146 Neuropilin antagonists
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256144 Pharmaceutical composition for treatment and prevention of cancers
10/20/2011	US20110256142 Novel methods and antibodies for treating cancer
10/20/2011	US20110256141 Monoclonal Antibodies Specific to the Fusion Peptide From Hemagglutinin From Influenza A Viruses and Uses Thereof
10/20/2011	US20110256140 Anti-hcv monoclonal antibody as a medicament for the theraputic treatment and prevention of hcv infections
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	US20110256138 Amyloid-beta binding proteins
10/20/2011	US20110256137 Pharmaceutical composition comprising a bispecific antibody for epcam
10/20/2011	US20110256133 Anti-polyubiquitin antibodies and methods of use
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256127 Anti-lrp6 antibodies
10/20/2011	US20110256125 Materials and methods for improved immunoglycoproteins
10/20/2011	US20110256122 Polypeptides, antibody variable domains & antagonists
10/20/2011	US20110256093 Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity
10/20/2011	US20110256062 Methods
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110256060 Monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therpay
10/20/2011	US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor
10/20/2011	CA2796339A1 Amyloid-beta binding proteins
10/20/2011	CA2796306A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011	CA2796248A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011	CA2796215A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	CA2796180A1 Monoclonal antibodies against her2 antigens, and uses therefor
10/20/2011	CA2796055A1 Human fgf receptor and .beta.-klotho binding proteins
10/20/2011	CA2796053A1 Methods and compositions for inhibition of treg cells
10/20/2011	CA2796010A1 Trail r2-specific multimeric scaffolds
10/20/2011	CA2795953A1 Antibodies for the treatment of clostridium difficile-associated infection and disease
10/20/2011	CA2795325A1 Fibronectin type iii domain-based multimeric scaffolds
10/20/2011	CA2795078A1 Proteins that bind pi16 and uses thereof
10/20/2011	CA2794863A1 Anti-vla-4 antibodies
10/20/2011	CA2793503A1 Anti-polyubiquitin antibodies and methods of use
10/20/2011	CA2792896A1 Method for the selection of a long-term producing cell
10/20/2011	CA2792717A1 Immunoglobulin aggregate removal
10/19/2011	EP2377936A2 Method for isolation of soluble polypeptides
10/19/2011	EP2377935A1 Method for isolation of soluble polypeptides
10/19/2011	EP2377932A1 ANTI-Siglec-15 ANTIBODY
10/19/2011	EP2377930A1 A group of esterases for the enantioselective production of fine and speciality chemicals
10/19/2011	EP2377891A1 Diagnosis and treatment of cancer using anti-lgr7 antibody

1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1494